Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with Novo Nordisk's recently launched Wegovy.

India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six dosage strengths. The once-weekly injector, known as Mounjaro KwikPen, now covers doses ranging from 2.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.